Peter G. Schultz
Affiliations: | 1985-1999 | University of California, Berkeley, Berkeley, CA, United States | |
| 1999- | Scripps Research Institute |
Website:
http://schultz.scripps.edu/schultz.phpGoogle:
"Peter G. Schultz"Bio:
http://www.nasonline.org/member-directory/members/64177.html
http://resolver.caltech.edu/CaltechETD:etd-06252004-112048
http://www.wolffund.org.il/index.php?dir=site&page=winners&cs=41&language=eng
The 1994/5 Wolf Prize in Chemistry: Richard A. Lerner and Peter G. Schultz for converting antibodies into enzymes, thus permitting the catalysis of chemical reactions considered impossible to achieve by classical chemical procedures.
Mean distance: 6.48 | S | N | B | C | P |
Parents
Sign in to add mentor| Peter B. Dervan | grad student | 1984 | Caltech | |
| (I. Ground and excited state studies of persistent 1,1-diazenes. II. Design of sequence specific DNA cleaving molecules) | ||||
| Christopher T. Walsh | post-doc | 1985 | MIT | |
Children
Sign in to add trainee
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Pigula M, Lai YC, Koh M, et al. (2024) An unnatural amino acid dependent, conditional Pseudomonas vaccine prevents bacterial infection. Nature Communications. 15: 6766 |
| Gupta AK, Pedroarena J, Nazarian A, et al. (2024) Identification of mCMQ069, a novel antimalarial with potential for a single-dose cure and/or 28-day chemoprevention. Biorxiv : the Preprint Server For Biology |
| Gupta AK, Eliasen AM, Andahazy W, et al. (2024) A Prodrug Strategy to Reposition Atovaquone as a Long-Acting Injectable for Malaria Chemoprotection. Biorxiv : the Preprint Server For Biology |
| Shim HS, Iaconelli J, Shang X, et al. (2024) TERT activation targets DNA methylation and multiple aging hallmarks. Cell |
| Riva L, Yuan S, Yin X, et al. (2024) Author Correction: Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing. Nature |
| Elshan NGRD, Wolff KC, Riva L, et al. (2024) Correction to "Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel Warhead". Journal of Medicinal Chemistry |
| Shao S, Zhang N, Specht GP, et al. (2024) Pharmacological expansion of type 2 alveolar epithelial cells promotes regenerative lower airway repair. Proceedings of the National Academy of Sciences of the United States of America. 121: e2400077121 |
| Dayan Elshan NGR, Wolff KC, Riva L, et al. (2024) Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel Warhead. Journal of Medicinal Chemistry |
| Grzelak EM, Elshan NGRD, Shao S, et al. (2023) Pharmacological YAP activation promotes regenerative repair of cutaneous wounds. Proceedings of the National Academy of Sciences of the United States of America. 120: e2305085120 |
| Ko Y, Hong M, Lee S, et al. (2023) S-lactoyl modification of KEAP1 by a reactive glycolytic metabolite activates NRF2 signaling. Proceedings of the National Academy of Sciences of the United States of America. 120: e2300763120 |